Autophagy receptor defects and ALS-FTLD

Area of Science:

• Neurodegenerative disorders
• Cellular biology
• Proteinopathy

Background:

• Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration (ALS-FTLD) are linked by complex pathophysiological mechanisms.
• Autophagy, a crucial intracellular catabolic pathway, is increasingly implicated in these neurodegenerative conditions.
• Dysfunctional autophagy can lead to the accumulation of toxic protein aggregates.

Purpose of the Study:

• To review the role of autophagy in the ALS-FTLD clinicopathological spectrum.
• To highlight the impact of genetic mutations on autophagic processes in ALS-FTLD.
• To explore the connection between autophagy and RNA processing in ALS-FTLD.

Main Methods:

• Literature review of recent studies on autophagy in ALS-FTLD.
• Analysis of genetic mutations affecting autophagy receptors and regulators.
• Examination of the link between autophagy and RNA processing pathways.

Main Results:

• Genetic mutations in autophagy-related proteins (ubiquilin-2, optineurin, SQSTM1/p62, VCP) disrupt autophagic clearance in ALS-FTLD.
• Impaired autophagy leads to the accumulation of pathological protein substrates.
• A direct link exists between autophagy and RNA processing, integrating several ALS-FTLD-associated genes.

Conclusions:

• Autophagy dysfunction is a key mechanism in the ALS-FTLD spectrum.
• Targeting autophagy may offer therapeutic strategies for ALS-FTLD.
• An integrated model connecting autophagy, RNA processing, and ALS-FTLD pathogenesis is supported.